Texas Health CoLab August Monthly Learning Series at THBD

 In Central Texas

The Texas Health CoLab Learning Series supports Austin’s health innovation ecosystem by offering classes, seminars and immersive workshops that are open to all Texas Health CoLab participants as well as the general public.

The Learning Series draws upon the expertise of industry leaders, clinicians, investors, and seasoned entrepreneurs to help innovators understand the opportunities and challenges of innovating in health care.

Learning Series events cover major trends in health care like precision medicine, digital health, big data, and artificial intelligence. They feature subject matter experts from a variety of fields, including product development, venture capital, privacy and data issues, and regulatory and patent law.

The Temple Health & Bioscience District (THBD) is one of the exclusive locations to live stream the Texas Health CoLab Learning Series. Come by THBD offices as we tune in together!

With the cost of technologies declining, why has the cost of health tech continued to rise? Can hospitals afford the latest innovations? This presentation will cover market needs and investment trends in Health IT and explore whether or not the two are aligned.

Join us for the August installment of the Learning Series to discover how the influx of capital has impacted the healthcare industry.

Thursday, August 29, 2019
3:00 – 4:30 p.m.

Temple Health & Bioscience District
1802 S. 1st Street
Temple, TX 76504

About the speaker:
Emma Cartmell is a proven health tech investor, following a 20-year career building, acquiring, selling and taking companies public. Ms. Cartmell served as the COO of NantHealth, a $1B private equity fund where she built the team and led investments and acquisitions. Before that, Ms. Cartmell was the COO of Personalized Medicine at Abraxis BioScience where she prepared the company for sale and helped negotiate an 8x revenue sale to Celgene for $2.9B. Earlier in her career, she was VP of Healthcare Advanced Programs and Director of Business Development at SAIC where she held both P&L and revenue-generating responsibilities for a $500M healthcare business. Ms. Cartmell has developed M&A strategies for public and private companies on both the buy and sell-side, with investment targets of up to $1B. She also advises the Morgan Stanley Equity Research team on the Digital Health Market. She personally invests in healthcare technology start-ups, both individually and as a member of the Central Texas Angel Network.

See their calendar for upcoming webinar topics and dates: https://www.templebioscience.org/events/

TEXAS HEALTH COLAB AUGUST MONTHLY LEARNING SERIES AT THBD

With the cost of technologies declining, why has the cost of health tech continued to rise? Can hospitals afford the latest innovations? This presentation will cover market needs and investment trends in Health IT and explore whether or not the two are aligned.

Join us for the August installment of the Learning Series to discover how the influx of capital has impacted the healthcare industry.

Thursday, August 29, 2019
3:00 – 4:30 p.m.

Temple Health & Bioscience District
1802 S. 1st Street
Temple, TX 76504

About the speaker:
Emma Cartmell is a proven health tech investor, following a 20-year career building, acquiring, selling and taking companies public. Ms. Cartmell served as the COO of NantHealth, a $1B private equity fund where she built the team and led investments and acquisitions. Before that, Ms. Cartmell was the COO of Personalized Medicine at Abraxis BioScience where she prepared the company for sale and helped negotiate an 8x revenue sale to Celgene for $2.9B. Earlier in her career, she was VP of Healthcare Advanced Programs and Director of Business Development at SAIC where she held both P&L and revenue-generating responsibilities for a $500M healthcare business. Ms. Cartmell has developed M&A strategies for public and private companies on both the buy and sell-side, with investment targets of up to $1B. She also advises the Morgan Stanley Equity Research team on the Digital Health Market. She personally invests in healthcare technology start-ups, both individually and as a member of the Central Texas Angel Network.